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Background: Most studies focusing on progression of BPH have been limited to the relationship between age and
BPH progression, and only few studies have focused on the time duration to start treatment. This study aimed to
investigate the association between self-perception period (S-PP) of lower urinary tract symptoms (LUTS) and International
Prostate Symptom Score (IPSS).
Methods: This study used data from two large-population surveys: a community-based survey and a university hospital
outpatient-based interview survey. Both surveys were conducted in male subjects aged 40 years or older who gave
consent to the survey questionnaire and voluntarily expressed their intention to participate. Propensity score matching
(PSM) was used to organize the population in both surveys into randomized groups to reduce selection bias. After
excluding those who had missing values, 483 subjects were assigned to each group by PSM.
Results: The S-PP of LUTS became significantly longer as the severity of LUTS increased. The S-PP was 4.15 years in
the mild group, 4.36 years in the moderate group, and 6.23 years in the severe group. These differences were statistically
significant. The correlation between S-PP of LUTS and IPSS was measured by partial correlation while controlling for age
(correlation coefficient = 0.20, p <0.001). Multiple regression analysis after controlling for age revealed that one-year
increase in the S-PP of LUTS significantly (p <0.001) increased IPSS by 0.322 points.
Conclusions: This study clarified the association between S-PP of LUTS and IPSS in a large-scale population. These
findings suggest that, from the perspective of public health, S-PP is an important risk factor for LUTS progression.
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Lower urinary tract symptoms (LUTS) of voiding and
storage commonly affect middle-aged men. European
EPIC study has estimated that LUTS is present in 62.5%
of middle-aged men (voiding symptoms, 25.7%; storage
symptoms, 51.3%) [1]. Korean EPIC study has estimated
that LUTS is present in 53.7% of middle-aged men (void-
ing symptoms, 28.5%; storage symptoms, 44.6%) [2].* Correspondence: leewj@korea.ac.kr
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unless otherwise stated.Benign prostatic hyperplasia (BPH), often causes void-
ing symptoms, a highly prevalent condition in middle-
aged men. In the United States, South Korea, the United
Kingdom, and Japan, the prevalence of BPH in age group
of 40s to 80s is reported to be 33%, 23%, 41%, and 37%,
respectively [3-6]. BPH, representing 80% of causes of
geriatric diseases associated with urination, is known to
cause decline in sexual function [7] and deterioration in
both urination-related [8] and health-related [9] quality
of life (QoL). BPH is a progressive disease, with most pa-
tients experiencing symptoms worsening over time
[10,11]. BPH does not suddenly appear as a disease. It
develops slowly in a natural process after subjectivehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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perception period (S-PP) of LUTS was considered as
one of the most important risk factors for BPH [12-14].
Escalating medical expenditures are a major concern
in many countries, especially those with populations
having high incidence of BPH. In the United States, al-
most 8 million visits were made with primary or second-
ary diagnosis of BPH. In 2000, the direct cost of BPH
treatment was estimated to be $1.1 billion, exclusive of
outpatient pharmaceuticals [15].
From the perspective of public health, identifying risk
factors for LUTS is useful to prevent LUTS and to im-
prove QoL. Olmsted County study [16], one of the largest
longitudinal studies conducted in America, investigated
age as one of many sociodemographic characteristics that
may predict the incidence of BPH. Age was also investi-
gated in a study that reanalyzed the same patients of the
Olmsted County study [17]. Thus, age is one of the most
reliable risk factors for the progression of BPH. Its influ-
ence is greater than those of other sociodemographic
characteristics. Likewise, most studies focusing on the nat-
ural history and progression of BPH have been limited to
the relationship between age and BPH progression. In
reality, the timing of the first hospital visit after LUTS is
different between individuals. In order to explain this
more comprehensively, Our previous studies adopted the
idea of an S-PP of LUTS from patient’s perspective be-
cause BPH is characterized by deep involvement of highly
subjective symptoms. These studies showed that the S-PP
of LUTS, in addition to age, acted as a major risk factor
for LUTS [12-14]. However, results from these studies
were insufficient to draw general conclusions due to their
small sample sizes, even though individuals were sampled
equally from large cities, small- and medium-sized cities,
and rural areas. The present study attempted to overcome
the limitations of previous studies and determine whether
S-PP of LUTS is a risk factor for LUTS using data ob-
tained from a community-based interview survey and an
interview survey of university hospital outpatients.
Methods
Subjects
The present study used data from two large-population
surveys: a community-based interview survey and a uni-
versity hospital outpatient-based interview survey. Both
were conducted with male subjects aged 40 years or
older who gave and wrote the informed consents to the
survey and voluntarily expressed their intention to par-
ticipate. This study was approved by the Institutional
Review Board of Korea University Ansan Hospital. In
order to enhance the validity of International Prostate
Symptom Score (IPSS), both surveys excluded the follow-
ing patients: 1) those who had undergone urological sur-
gery which might affect their IPSS score; 2) those who hadreceived any treatment for BPH or prostate cancer; 3)
those who had evidence of neurological condition, un-
controlled diabetes mellitus, un-controlled hypertension,
history of malignancy, urinary tract infection within
3 months, psychiatric illness with medications and alcohol
or substance abuse; 4) those who were taking or had taken
any drug for the same complaints.
Community-based interview survey
One investigator visited senior welfare centers in South
Korea between May 2010 and April 2013 and carried out
a survey of 1,030 males using the IPSS questionnaire. Dur-
ing this period, the survey was conducted over a total of
36 times in six metropolitan areas of the country: Seoul,
Gyeonggido, Incheon, Daejeon, Daegu, and Busan. In
total, the study had a sample size of 518 subjects after ex-
cluding those described above.
University hospital outpatients-based survey
Another IPSS questionnaire survey was performed with
2,493 male outpatients who visited university hospitals
in South Korea between September 2010 and September
2011. The survey included 20 university hospitals in nine
major areas of the country: Seoul, Gyeonggido, Incheon,
Daejeon, Daegu, Busan, Gangwondo, Gwangju, and
Ulsan. In total, the study had a sample size of 1,278 sub-
jects after excluding those described above.
Study design and measuring tools
This was a cross-sectional study. To evaluate the factors
that might affect the severity of LUTS, the study investi-
gated age, S-PP, and IPSS.
IPSS questionnaire
The severity of LUTS was measured by IPSS based on
the American Urological Association (AUA) symptom
index, with one additional question on quality of life.
IPSS questionnaire has been translated into many differ-
ent world languages and adapted based on the circum-
stances of each country. IPPS questionnaire is now
widely used for objective assessment of LUTS [6,18].
The Korean version of the IPSS verified by Choi et al. in
terms of relevance and reliability is now the most typical
diagnostic instrument for LUTS in Korea [19].
The IPSS questionnaire consisted of eight items, which
included seven 6-point scale questions on symptoms (feel-
ing of incomplete emptying, urinary frequency, inter-
rupted stream, urinary urgency, weak urinary stream,
urinary hesitancy, and nocturia) and one 7-point scale
question on patient’s satisfaction with their urinary condi-
tion. Based on the criteria of Barry et al., symptom severity
was divided into three groups: mild (a symptom score of
0–7), moderate (8–19), and severe (20–35) [20]. The qual-
ity of life or level of satisfaction of LUTS patients was
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satisfied), “I’m all right” (1 point), “Somewhat satisfied” (2
points), “Half-satisfied, half-dissatisfied” (3 points), “Some-
what dissatisfied” (4 points), “Distressed” (5 points), and “I
can’t stand it” (6 points = very dissatisfied).
Age questionnaire
Age as an important factor has impact on generation-
specific prevalence, IPSS, and S-PP of LUTS. Therefore,
this study queried each participant’s date of birth.
S-PP of LUTS
The S-PP of LUTS was defined as the period between
the moment the participant perceived any inconvenience
resulting from LUTS (feeling of incomplete emptying,
interrupted stream, urgency, weak urinary stream, hesi-
tancy, or nocturia) and the time the interview survey
was conducted. The longest periods of any LUTS symp-
toms were regarded as S-PPs.
Reliability
Cronbach’s α was 0.652 for the seven 6-point scale ques-
tions about symptoms and the one 7-point scale ques-
tion on satisfaction with urinary conditions, indicating
acceptable internal consistency and reliability. Internal
consistency with each item excluded did not substan-
tially change the observed value. The reliability of the
questionnaire used in this study was estimated to be
similar to, or at least not lower than, that in previous
studies [14]. This suggested that we used the same
method as previous studies. The interview survey of uni-
versity hospital outpatients was conducted by well-
trained professional investigators. The present survey
enrolled hospital patients through a formal procedure in
compliance with the guidelines of the individual hospi-
tals’ institutional ethics committees.
Propensity score matching
Propensity score matching (PSM) was used to organize
the population in both surveys into randomized groups
to reduce selection bias in sampled population. Since the
population of this study included two different groups of
people, those “who do not visit hospitals” (in the
community-based interview survey) and those “who visit
hospitals” (in the interview survey of university hospital
outpatients), we allowed Berkson’s bias which may result
from differences in characteristics between the two
groups [21]. PSM typically involves the formation of
pairs of treated and untreated subjects with similar pro-
pensity score (PS) values. Hence, a logistic regression
model was used to calculate and save the predicted
probability of the dependent variable and the PS for each
observation in the data set. This single score (between 0
and 1) represented the relationship between multiplecharacteristics and the dependent variable as a single
characteristic. Age and S-PP, whose significance was
established in previous studies [12-14], were used as in-
dependent variables in the analysis.
In this study, in-caliper nearest-neighbor matching
proposed by Rosenbaum and Rubin was taken into con-
sideration as a PSM method. Rosenbaum and Rubin sug-
gest use caliper value equal to 0.25 of the standard
deviation of the logit of the PS [22]. Accordingly, this
study used a caliper of 0.25 times the standard deviation
of the PS. Furthermore, one-to-one matching was per-
formed in order to optimize possible effects through sev-
eral simulations. Excluding those with missing values,
483 subjects were selected from each group using PSM.
In this study, the multivariate imbalance measure de-
creased from 0.50 before PSM to 0.28 after PSM. The
implementation of PSM was accordingly evaluated to be
appropriate.
Statistical analysis
In order to examine the association between BPH and re-
lated risk factors, we analyzed distribution patterns before
and after performing PSM. We performed t-test on indi-
vidual variables to determine whether the confounder was
properly controlled between the non-visiting group (for
the community-based interview survey) and the visiting
group (for the interview survey of university hospital out-
patients). For the prevalence of BPH, a frequency analysis
was performed on IPSS scores. A one-way ANOVA was
carried out to examine the relationships between different
BPH severity groups. In an attempt to examine the correl-
ation between the IPSS and the S-PP of LUTS, partial cor-
relation coefficient was measured while controlling for
age. A multiple linear regression analysis was conducted
to assess how IPSS had changed over a year with respect
to risk factors for BPH. In the analysis, independent vari-
ables included age and the S-PP of LUTS, both reported
to be significant in previous studies [12-14]. The IPSS was
used as a dependent variable. The significance of multicol-
linearity was assessed by comparing the variation inflation
factors (VIFs) between independent variables.
All data were presented as mean and standard devi-
ation (SD). Statistical analysis was performed using SPSS
version 21.0 software (IBM, New York, NY, USA) with
an R module available for PS analysis. All statistics were
two-tailed and p-values <0.05 were considered to be
significant.
Results
Characteristics of participants before and after PSM
With age and S-PP of LUTS as covariates, propensity
scores were estimated as the probability of a hospital
visit. The distributions of subjects before and after PSM
are shown in Figure 1. The distributions of the non-
Figure 1 Comparison of differences of variables between the two groups using histogram (a) and box plot (b) before and after propensity
score matching. Community-based group did not visit hospitals. University hospital outpatients-based group visited hospitals.
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view survey) and the visiting group (subjects in the
interview survey of university hospital outpatients) be-
fore and after PSM were found to be similar to each
other in terms of age or S-PP of LUTS (Figure 1a).
Before PSM, the mean propensity scores ranged from
0.46 to 0.72 for the non-visiting group and from 0.64 to
0.92 for the visiting group. The small area of overlap be-
tween the two groups indicated that a small number of
subjects had similar characteristics. However, when thenon-visiting and visiting group (n = 483 per group) were
matched one-to-one after PSM, the two groups had the
same mean propensity score of approximately 0.6 with a
similar distribution (Figure 1b). After PSM, 483 participants
were included in each of the non-visiting and visiting
groups. The mean age of community-based survey and
hospital outpatients’ survey were 74.5 ± 6.06 and 74.3 ±
6.19 years, respectively. There was no statistically significant
difference between the two groups in all variables except
for IPSS (Table 1).
Table 1 Comparison of variables between the two groups
after propensity score matching
Community* n = 483 Hospital† n = 483 P‡
Mean SD Mean SD
Age (years) 74.5 6.06 74.3 6.19 0.560
IPSS 15.3 8.16 18.1 7.61 0.000
S-PP (years) 5.0 5.16 5.0 4.79 0.998
PS§ 0.61 0.15 0.62 0.15 0.618
*Community-based group, those who do not visit hospitals. †University hospital
outpatient-based group, those who visit hospitals. ‡P-value, student t-test analysis.
§Propensity score. IPSS, international prostate symptom score; S-PP, self-perception
period of lower urinary tract symptoms.
Table 3 Self-perception period of lower urinary tract
symptoms based on severity
n (966) S-PP (years) P*
Mean SD
Mild 120 4.15† 3.95 <0.001
Moderate 512 4.36† 4.27
Severe 334 6.23 5.97
*P-value, one-way analysis of variances. †Same letters indicate no statistical
significance based on Tukey’s multiple comparison. S-PP: self-perception
period of lower urinary tract symptoms.
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The distribution of IPSS scores were classified into three
groups: mild group (n = 120, 12.4%), moderate group
(n = 512, 53.0%), and severe group (n = 334, 34.6%). By
age, 87.5% of patients in their 50s, 55.3% of those in their
60s, 53.9% of those in their 70s, and 46.2% of those aged
over 80 years belonged to the moderate group. Therefore,
as age increased, the proportion of patients in the moder-
ate group was reduced. On the other hand, 12.5% of pa-
tients in their 50s, 33.5% of those in their 60s, 34.0% of
those in their 70s, and 38.5% of those aged over 80 years
belonged to the severe group. Therefore, as age increased,
the proportion of patients in the severe group was also in-
creased (Table 2).
S-PP of LUTS
The S-PP was shown to be 4.15 years for the mild group,
4.36 years for the moderate group, and 6.23 years for the
severe group. These differences were statistically signifi-
cant. A post-hoc Tukey’s test revealed that the severe
group showed a significantly longer perception period
than the other groups. However, there was no statistical
difference between the mild group and the moderate
group. Therefore, as the severity of disease increased,
the S-PP of LUTS became longer (Table 3).
Correlation between S-PP of LUTS and IPSS
The correlation between S-PP and IPSS was measured
by Pearson’s partial correlation while controlling for age,Table 2 Age-specific IPSS severity and prevalence of LUTS




50-59 60-69 70-79 over 80 Total
Mild 0 (0) 22 (11.2) 70 (12.1) 28 (15.4) 120 (12.4)
Moderate 7 (87.5) 109 (55.3) 312 (53.9) 84 (46.2) 512 (53.0)
Severe 1 (12.5) 66 (33.5) 197 (34.0) 70 (38.5) 334 (34.6)
Total 8 (100) 197 (100) 579 (100) 182 (100) 966 (100)
Values are numbers with percentages in parentheses. IPSS: international
prostate symptom score; LUTS: lower urinary tract symptoms.which has a significant impact on both variables, with
IPSS and S-PP of LUTS as control variables, S-PP of
LUTS as an independent variable, and IPSS as a
dependent variable. A weak correlation with a correl-
ation coefficient of 0.20 was found (p <0.001; Table 4).
Association between S-PP of LUTS and IPSS
A multiple linear regression analysis was performed to as-
sess how IPSS had changed over a year with respect to risk
factors for LUTS. The IPSS was used as a dependent vari-
able. Result of regression analysis found that a one-year
increase in the S-PP of LUTS significantly (p <0.001) in-
creased IPSS by 0.322 points and a standardized coeffi-
cient (β) of 0.200 (p <0.001). Age did not show a
statistically significant increase in IPSS. The VIF among
independent variables was 1.006. Multicollinearity was not
significant (Table 5).
Discussion
LUTS is common in elderly men. This was confirmed in
the present study. Especially, BPH symptoms become
more severe as age increases. This result is similar to
those of previous studies [3-6]. BPH can be associated
with a number of health-related problems relevant to
older men, including increased risk of acute urinary re-
tention, sexual dysfunction, and BPH-related surgery
[7,8]. In light of the high prevalence of BPH in older
men, increasing life expectancy and retaining a good
QoL for older patients requires addressing therapeutic
issues and identifying the risk factors of BPH in the gen-
eral population.
The risk factors for BPH can be seen from two per-
spectives. The first involves the sociodemographic char-
acteristics of patients, which include age, family history,
race, and ambient temperature [10,16,17]. The secondTable 4 Partial correlation between self-perception period
of LUTS and IPSS
n r* P
After propensity score matching 966 0.200 <0.001
*Pearson’s partial correlation coefficient adjusted for age. IPSS: international
prostate symptom score; S-PP: self-perception period of lower urinary tract symptoms.
Table 5 Multiple linear regressions analysis of self-perception
period of LUTS and IPSS
B* S. E. β† P
Age (years) 0.013 0.041 0.010 0.75 (n = 966)
S-PP (years) 0.322 0.051 0.200 <0.001
*Unstandardized coefficient. †Standardized coefficient. IPSS: international
prostate symptom score; S-PP: self-perception period of lower urinary
tract symptoms.
Shim et al. BMC Urology  (2015) 15:30 Page 6 of 7includes biological factors, which include age, peak urine
flow, prostate volume, PSA, and sense of residual urine
[23]. This study placed its focus on sociodemographic
characteristics. The self-perception period of LUTS could
be considered as one of the most important risk factors
for LUTS along with age. Emberton et al. reported that
the natural history of LUTS, such as urinary frequency, ur-
gency, nocturia, interrupted stream, weak urinary stream,
and sense of residual urine might vary with age [24].
In the correlation analyses of previous studies, the cor-
relation coefficient between age and IPSS was shown to
be 0.17 [25] or 0.377 [26]. Age is one of the reliable risk
factors for progression of BPH. Influence of age was the
greatest among sociodemographic characteristics. Mean-
while, when controlling for age, partial correlation coef-
ficient in the present study between the S-PP of LUTS
and IPSS showed a significant correlation (partial correl-
ation coefficient = 0.20, p <0.001). These findings suggest
that S-PP, in addition to age, is an important risk factor
for LUTS progression.
Assessing the progression of BPH by natural history
and the Olmsted County study, one of the largest longi-
tudinal studies conducted in America, was focused on
age. This study was conducted on 2,115 patients over
42 months. In this study, IPSS was increased by 0.18
points on a yearly basis [16]. In a study that reanalyzed
the same patients in the 66th and 92nd month, a 0.3
point [17] increase was observed, respectively. Thus, age
is one of the most reliable risk factors for the progres-
sion of LUTS. Its influence is the greatest of all sociode-
mographic characteristics. However, in our study, a
regression analysis with age and S-PP revealed that
yearly increases of age. IPSS was increased by 0.013
points (p = 0.75) as age was increased yearly without
statistical significance. Age was not a significant pre-
dictor of increase in IPSS severity because both large-
population surveys did not control for age-generation dis-
tributions. Consequently, almost half of the participants
were over 70 years old. We also found that as S-PP of
LUTS was increased by 1 year, IPSS would increase by
0.322 points (P <0.001), which was a greater change than
what was seen for age. The induced regression equation
was as follows: IPSS = 14.109 + 0.322 (S-PP) + 0.0 13 (age).
In the event when S-PP and age were increased by 1 year,
IPSS could be increased by as much as 0.335 points. Thisresult is smaller than the 0.868 points (p <0.001) found in
a previous study using the same methodology [14]. The
results of this regression analysis confirmed the results of
correlation analysis described above. That is, from the per-
spective of public health, the S-PP of LUTS might be a
more confident sociodemographic characteristic than age.
Emberton et al. raised the issue that, although the no-
tion of disease progression in BPH is generally accepted,
there remains uncertainty about the rate and the determi-
nants of progression. In a review on placebo arms of clin-
ical trials of BPH, progression was observed in terms of
increasing prostate volume, decrease in urinary flow rate,
and an increase in the future risk of acute urinary reten-
tion and surgery. By contrast, symptom score was shown
to be improved in placebo groups, probably as a result of
the “placebo effect” and the “white coat effect” [27,28]. In
reality, however, the time of the first visit to a hospital
after perceiving LUTS differs between individuals. The
S-PP of symptoms could mean the “self-delayed time”
before visiting a health provider. It could be affected by
various sociodemographic characteristics. Several stud-
ies have shown that several sociodemographic risk fac-
tors could affect the “self-delayed time” before the first
visit to healthcare provider [13,24,29,30]. The S-PP of
LUTS before treatment could have a strong relationship
with symptom severity at the time of first medical visit.
The present study demonstrated that LUTS develop-
ment depended on the period of patient’s subjective
perception.
The present study has several limitations. Sample selec-
tion bias is unavoidable in observational studies. The gen-
eral characteristics of patients were uncontrollable in both
surveys. There were many missing values in both surveys
due to sample selection bias. These results were analyzed
using two independent variables (age and the S-PP of
LUTS) whose significance was established in previous
studies [14]. Therefore, it did not represent the whole
population of men aged 40 years or older. Furthermore,
PSM only accounted for observed covariates. Unobserv-
able covariates cannot be accounted for in the matching
procedure. In addition, there was an obvious correlation
between IPSS and the S-PP of LUTS. However, a causal
relationship could not be observed. Therefore, in the fu-
ture, a large-scaled active controlled study is needed using
a sociodemographically representative population.Conclusions
This study clarifies the association between the S-PP of
LUTS and IPSS in a large-scale population. These find-
ings suggest that, from the perspective view of public
health, S-PP is an important risk factor for LUTS pro-
gression. Further longitudinal studies are needed to in-
vestigate the real predictive effect of S-PP.
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